P-159 - QUANTITATIVE DISCRIMINATION OF CUTANEOUS PHARMACOKINETIC PROFILES FOR TOPICAL DRUG PRODUCTS.

S. Shukla¹, T. Ramezanli¹, E. Rantou¹, K. Tiffner², T. Birngruber², F. Sinner^2,3, S. Raney¹; ¹US Food and Drug Administration, Silver Spring, MD, USA, ²HEALTH-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Graz, Austria, ³Medical University of Graz, Graz, Austria.